William A Haseltine

William A. Haseltine PhD has an active career in both science and business. He was a professor at Harvard Medical School and Harvard School of Public Health from 1976-1993 where he was Founder and the Chair of two academic research departments. He is well known for his pioneering work on cancer, HIV/AIDS and genomics. He has authored more than 200 manuscripts in peer-reviewed journals and is the author of several books. He is the Founder of Human Genome Sciences, Inc and served as the Chairman and CEO of the Company until 2004. He is also the Founder of several other successful biotechnology companies. Companies he has founded account for five drugs currently on the market including Benlysta and ABTRAX (Human Genome Sciences,Inc), Velcade (Proscript/Leucocyte,Inc), and Provenge (Dendreon,Inc). William Haseltine is currently Chairman and President of ACCESS Health International, Inc (www.accessh.org) that supports access to affordable, high quality health services in low, middle and high income countries, and Chairman Haseltine Foundation for Science and the Arts that fosters a dialog between sciences and the arts. He is an advisor to several governments, biotechnology and pharmaceutical companies. He is a member of the Advisory Board of the IE University, Madrid, the Advisory Council for the Koch Institute of MIT and the Life Sciences Foundation, a member of the Advisory Boards of the Ragon Institute , The Rockefeller University Council, and The FXB Center for Health and Human Rights at the Harvard School of Public health. He is a Lifetime Governor of the New York Academy of Sciences and a member of the Board of AID for AIDS International. He is an honorary member of the Board of Trustees of the Brookings Institution, a member of the Council on Foreign Relations, He is a member of the Advisory Board of the Metropolitan Opera, New York, a member of the Chairman’s Council of the Metropolitan Museum, New York, a Member of the International Council of the Guggenheim Museum, The International Council of The Tate Modern, a Member of Board of Directors of the Young Concert Artists, Inc. and the Youth Orchestra of the Americas, The American Friends of the Budapest Orchestra, and the China Arts Foundation.